Sichuan Kelun Pharmaceutical Co., Ltd. (SHE:002422)
China
· Delayed Price · Currency is CNY 34.10
+1.50 (4.60%)
Apr 29, 2026, 3:04 PM CST
SHE:002422 Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Apr '26 Apr 28, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | 2021 - 2017 |
| Market Capitalization | 54,234 | 46,689 | 47,480 | 42,829 | 37,335 | 26,621 | Upgrade
|
| Market Cap Growth | -3.35% | -1.67% | 10.86% | 14.71% | 40.25% | -4.25% | Upgrade
|
| Enterprise Value | 54,869 | 47,890 | 49,788 | 47,019 | 45,807 | 36,189 | Upgrade
|
| Last Close Price | 34.10 | 29.35 | 29.44 | 27.66 | 24.83 | 17.25 | Upgrade
|
| PE Ratio | 34.44 | 27.43 | 16.17 | 17.44 | 21.89 | 24.15 | Upgrade
|
| Forward PE | 27.63 | 23.59 | 15.69 | 21.36 | 21.81 | 18.84 | Upgrade
|
| PS Ratio | 2.95 | 2.52 | 2.18 | 2.00 | 1.96 | 1.54 | Upgrade
|
| PB Ratio | 1.82 | 1.59 | 1.78 | 1.86 | 2.21 | 1.88 | Upgrade
|
| P/TBV Ratio | 2.32 | 2.04 | 2.24 | 2.34 | 2.59 | 2.10 | Upgrade
|
| P/FCF Ratio | 66.10 | 45.79 | 16.87 | 12.00 | 16.74 | 14.34 | Upgrade
|
| P/OCF Ratio | 22.21 | 17.67 | 10.57 | 8.03 | 11.94 | 9.35 | Upgrade
|
| EV/Sales Ratio | 2.98 | 2.59 | 2.28 | 2.19 | 2.41 | 2.10 | Upgrade
|
| EV/EBITDA Ratio | 17.86 | 14.10 | 9.49 | 10.23 | 13.41 | 13.45 | Upgrade
|
| EV/EBIT Ratio | 32.64 | 22.75 | 12.31 | 13.80 | 20.27 | 24.39 | Upgrade
|
| EV/FCF Ratio | 66.88 | 46.97 | 17.69 | 13.18 | 20.54 | 19.49 | Upgrade
|
| Debt / Equity Ratio | 0.14 | 0.14 | 0.16 | 0.31 | 0.67 | 0.84 | Upgrade
|
| Debt / EBITDA Ratio | 1.21 | 1.21 | 0.79 | 1.54 | 3.28 | 4.41 | Upgrade
|
| Debt / FCF Ratio | 4.13 | 4.13 | 1.50 | 2.00 | 5.06 | 6.42 | Upgrade
|
| Net Debt / Equity Ratio | -0.13 | -0.13 | -0.08 | 0.01 | 0.36 | 0.61 | Upgrade
|
| Net Debt / EBITDA Ratio | -1.15 | -1.15 | -0.43 | 0.04 | 1.79 | 3.21 | Upgrade
|
| Net Debt / FCF Ratio | -3.84 | -3.84 | -0.80 | 0.05 | 2.74 | 4.65 | Upgrade
|
| Asset Turnover | 0.48 | 0.48 | 0.59 | 0.61 | 0.58 | 0.54 | Upgrade
|
| Inventory Turnover | 2.55 | 2.55 | 2.78 | 2.92 | 2.76 | 2.34 | Upgrade
|
| Quick Ratio | 1.55 | 1.55 | 1.39 | 1.32 | 1.04 | 0.74 | Upgrade
|
| Current Ratio | 2.18 | 2.18 | 1.96 | 1.83 | 1.38 | 1.05 | Upgrade
|
| Return on Equity (ROE) | 6.70% | 6.70% | 13.51% | 13.27% | 11.00% | 6.17% | Upgrade
|
| Return on Assets (ROA) | 3.41% | 3.41% | 6.85% | 6.03% | 4.30% | 2.92% | Upgrade
|
| Return on Invested Capital (ROIC) | 6.54% | 6.59% | 13.30% | 10.90% | 8.14% | 4.75% | Upgrade
|
| Return on Capital Employed (ROCE) | 6.90% | 6.90% | 14.40% | 12.90% | 10.20% | 8.20% | Upgrade
|
| Earnings Yield | 2.90% | 3.65% | 6.18% | 5.73% | 4.57% | 4.14% | Upgrade
|
| FCF Yield | 1.51% | 2.18% | 5.93% | 8.33% | 5.97% | 6.97% | Upgrade
|
| Dividend Yield | 1.82% | 2.02% | 2.59% | 2.89% | 2.48% | 2.47% | Upgrade
|
| Payout Ratio | 68.69% | 64.09% | 61.70% | 45.87% | 60.60% | 90.33% | Upgrade
|
| Buyback Yield / Dilution | -0.77% | -0.77% | -2.18% | -4.17% | -4.91% | 1.15% | Upgrade
|
| Total Shareholder Return | 1.02% | 1.25% | 0.41% | -1.28% | -2.43% | 3.62% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.